explore -WSS

explore

author：explore 2025-09-07 13:59:13 - browse：17767

he exterior of the U.S. Capitol building is seen at sunrise — Sarah Silbiger/Getty Images

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills.

The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today. The policies are not identical, but at least three PBM reforms have been passed by panels in both chambers:

One that would replace PBM fees that are tied to a percentage of drug prices with flat fees
Another that would require Medicare to create standard performance measures on which PBMs base pharmacy payments
A third that would require PBMs to report a host of information, including drug costs, savings, beneficiary out-of-pocket costs, payments to pharmacies, and the amount of business directed to PBM-owned pharmacies

The Energy & Commerce subcommittee also passed other bills that mirror legislation that Senate Finance also has passed. That includes legislation to ensure seniors pay no more for drugs than insurers, and a measure that lets insurers add less-expensive biosimilars to formularies mid-year.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Ed Silverman on new gene therapies, biosimilars, coffee, and more

WSS

In rare move, senator releases unverified FBI source report alleging Biden bribe

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Ed Silverman on new gene therapies, biosimilars, coffee, and more

Why palliative psychiatry is worth discussing

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

knowledge

explore

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

FDA approval of Sarepta Duchenne genetic therapy gives me hope

NIH study of ME/CFS points to clear biological hallmarks

Malaria cases in Florida and Texas: Here’s what you need to know

Why palliative psychiatry is worth discussing

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Heart attack and stroke risk calculators need revising

US jobless claims fall again as labor market continues to flash strength

Wikipedia

Mystery swirls around US soldier who entered North Korea days ago, officials say

A new nitrogen execution bill also undermines medical licensing

'CMA Fest' 2023: How to watch, who is performing and more

Eli Lilly to acquire DICE Therapeutics in $2.4 billion deal

Scientists grapple with ethics of stem cell research

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

focus

hotspot

leisure time

hotspot